In one NSCLC patient, harboring KIF5B-RET rearrangement, circulating tumor DNA and post-mortem biopsy analysis showed the appearance of a wide spectrum of RET mutations on G810 residue (solvent front mutations), concomitantly with progression of the disease. This evidence concerns the gene RET and non-small cell lung carcinoma.